Gian Paolo Spinelli - Concepedia

Author

Gian Paolo Spinelli

Also Known As

CARDINALE, VINCENZO, Corrado Spatola, G P Spinelli, G Spinelli, G. Spinelli, G.P. Spinelli, GIAN PAOLO SPINELLI, Gian Paolo Spinelli, Gian P. Spinelli, Gian Paolo Spinelli

104

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome Università Campus Bio-Medico Ospedale Santa Maria Goretti Istituti di Ricovero e Cura a Carattere Scientifico Ospedale Policlinico San Martino

About

Gian Paolo Spinelli is an author at Sapienza University of Rome specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	211
2	Immunology	4	4	119
3	Cell Biology	3	3	81
4	Health Sciences	1	1	20
5	Orthopaedics	1	1	20

Gian Paolo Spinelli

Publications

677

Citations

H-Index

Page 1

	Year	Citations
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy Alessio Cortellini, Massimo Di Maïo, Olga Nigro, Journal for ImmunoTherapy of Cancer	2021	132
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario Luca Cantini, Giulia Mentrasti, Gian Luigi Russo, ESMO Open	2022	62
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens Alessio Grimaldi, Ilenia Cammarata, Carmela Martire, Communications Biology	2020	46
Breast cancer metastatic to the pituitary gland: a case report Gian Paolo Spinelli, Giuseppe Lo Russo, Evelina Miele, World Journal of Surgical Oncology	2012	38
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, European Journal of Cancer Prognostic BiomarkersDrug-based ScoreOncologyImmunologyImmune Surveillance	2021	36
Immunogenicity of Allo-Vesicle Carrying ERBB2 Tumor Antigen for Dendritic Cell-Based Anti-Tumor Immunotherapy Chiara Napoletano, Aurelia Rughetti, Rachele Landi, International Journal of Immunopathology and Pharmacology ImmunologyImmunoeditingExtracellular MicrovesiclesImmunotherapyTumor Biology	2009	34
Long-term survival in metastatic pancreatic cancer. A case report and review of the literature. Gian Paolo Spinelli, Angelo Zullo, Adriana Romiti, PubMed	2006	34
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population Margherita Rimini, Lorenzo Fornaro, Mario Domenico Rizzato, European Journal of Cancer MedicineBiliary CancerPathologyAnti-cancer AgentCancer Treatment	2024	34
High-throughput microRNA profiling of pediatric high-grade gliomas Evelina Miele, Francesca Romana Buttarelli, Federica Begalli, Neuro-Oncology	2013	33
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study Alessio Cortellini, Katia Cannita, Marcello Tiseo, European Journal of Cancer Prognostic BiomarkersOncologyDisease ProgressionPd-l1 ExpressionPost-progression Outcomes	2021	29

Page 1